|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 卒中一级预防指南 美国心脏协会/美国卒中协会为医疗卫生专业人员制定的指南美国神经病学学会肯定本指南作为神经科医生继续教育工具的价值显示文摘背景和目的本指南对各种已确定和新出现的卒中危险因素的证据进行概述,以提供降低首次卒中风险的循证推荐。方法写作组成员由委员会主席根据每位成员先前在相关课题领域中的工作提名,并经美国心脏协会(American HeartAssociation,AHA)卒中委员会科学声明监督委员会批准。写作组采用系统文献回顾的方法(涵盖时间为2006年上一次回顾发表到2009年4月),参考先前已发表的指南、个人文件和专家意见来总结现有证据,并指出现有知识的差距;如果合适,则根据标准的AHA标准做出推荐。写作组全体成员均有机会对推荐进行评论并审核这份声明的最终文本。在AHA科学咨询和协调委员会考察和批准之前,本指南已南卒中委员会领导层和AIIA科学声明督察委员会进行过广泛的同行评议。结果对评价个体首次卒巾风险的流程图进行了评价。根据干预的町能性(不可于预、可于预或潜在可干预)和证据的强度(证据充分或证据不太充分),对首次卒中的危险因素或风险标记物进行分类。不可干预危险因素包括年龄、性别、低出生体质量、人种/种族和遗传倾向。证据充分的叮干预危险因素包括高血压、吸烟、糖尿病、心房颤动和某些其他心脏病、血脂异常、颈动脉狭窄、镰状细胞病、绝经后激素治疗、不良饮食习惯、体力活动过少以及肥胖和体脂分布。证据不太充分或潜在的可干预危险因素包括代谢综合征、酗酒、药物滥用、口服避孕药、睡眠呼吸障碍、偏头痛、高同型半胱氨酸血症、脂蛋白(a)升高、高凝状态、炎症和感染。对用阿司匹林进行卒中一级预防的资料进行了回顾。结论多方面的证据可用于确定能增高首次卒中风险的多种具体因素并提供降低这种风险的策略。 | Larry B. Goldstein Cheryl D. Bushnell Robert J. Adams Lawrence J. Appel Lynne T. Braun Seemant Chaturvedi Mark A. Creager Antonio Culebras Robert H. Eckel Robert G. Hart Judith A. Hinchey Virginia J. Howard Edward C. Jauch Steven R. Levine James F. Meschia Wesley S. Moore J.V. (Ian) Nixon Thomas A. Pearson 张霞(译) 尤寿江(译) 陈孝东(译) 卢涛声(译) 石际俊(译) 曹勇军(译) 徐兴顺(译) | 2010 | 国际脑血管病杂志2010，18，12： | 12 |
| 2 | AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute显示文摘 | Sidney C. Smith Jerilyn Allen Steven N. Blair Robert O. Bonow Lawrence M. Brass Gregg C. Fonarow Scott M. Grundy Loren Hiratzka Daniel Jones Harlan M. Krumholz Lori Mosca Richard C. Pasternak Thomas Pearson Marc A. Pfeffer Kathryn A. Taubert | 2006 | Circulation2006，，19： | 4 |
| 3 | Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema显示文摘 | Peter A. Campochiaro David M. Brown Andrew Pearson Thomas Ciulla David Boyer Frank G. Holz Michael Tolentino Amod Gupta Lilianne Duarte Steven Madreperla John Gonder Barry Kapik Kathleen Billman Frances E. Kane | 2011 | Ophthalmology2011，，4： | 2 |
| 4 | Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association显示文摘 | Thomas A. Pearson George A. Mensah R. Wayne Alexander Jeffrey L. Anderson Richard O. Cannon Michael Criqui Yazid Y. Fadl Stephen P. Fortmann Yuling Hong Gary L. Myers Nader Rifai Sidney C. Smith Kathryn Taubert Russell P. Tracy Frank Vinicor | 2003 | Circulation: Journal of the American Heart Association2003，，3： | 2 |
| 5 | Elevated lipoprotein(a) levels in South Asians in North America显示文摘 | Sonia S. Anand Enas A. Enas Janice Pogue Steven Haffner Thomas Pearson Salim Yusuf | 1998 | Metabolism1998，，： | 1 |
| 6 | Pooled Analyses of Effects on C-Reactive Protein and Low Density Lipoprotein Cholesterol in Placebo-Controlled Trials of Ezetimibe Monotherapy or Ezetimibe Added to Baseline Statin Therapy显示文摘 | Thomas A. Pearson Christie M. Ballantyne Enrico Veltri Arvind Shah Steven Bird Jianxin Lin Elizabeth Rosenberg Andrew M. Tershakovec | 2009 | The American Journal of Cardiology2009，，3： | 1 |
| 7 | AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update显示文摘 | Sidney C. Smith Jerilyn Allen Steven N. Blair Robert O. Bonow Lawrence M. Brass Gregg C. Fonarow Scott M. Grundy Loren Hiratzka Daniel Jones Harlan M. Krumholz Lori Mosca Richard C. Pasternak Thomas Pearson Marc A. Pfeffer Kathryn A. Taubert | 2006 | Journal of the American College of Cardiology2006，，10： | 1 |
| 8 | Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group I: Epidemiology显示文摘 | Barbara V. Howard Beatriz L. Rodriguez Peter H. Bennett Maureen I. Harris Richard Hamman Lewis H. Kuller Thomas A. Pearson Judith Wylie-Rosett | 2002 | Circulation: Journal of the American Heart Association2002，，18： | 1 |
| 9 | AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update显示文摘 | Sidney C. Smith Jerilyn Allen Steven N. Blair Robert O. Bonow Lawrence M. Brass Gregg C. Fonarow Scott M. Grundy Loren Hiratzka Daniel Jones Harlan M. Krumholz Lori Mosca Richard C. Pasternak Thomas Pearson Marc A. Pfeffer Kathryn A. Taubert | 2006 | Journal of the American College of Cardiology2006，，10： | 1 |
| 10 | Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association显示文摘 | Thomas A. Pearson George A. Mensah R. Wayne Alexander Jeffrey L. Anderson Richard O. Cannon Michael Criqui Yazid Y. Fadl Stephen P. Fortmann Yuling Hong Gary L. Myers Nader Rifai Sidney C. Smith Kathryn Taubert Russell P. Tracy Frank Vinicor | 2003 | Circulation: Journal of the American Heart Association2003，，3： | 1 |
| 11 | AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute显示文摘 | Sidney C. Smith Jerilyn Allen Steven N. Blair Robert O. Bonow Lawrence M. Brass Gregg C. Fonarow Scott M. Grundy Loren Hiratzka Daniel Jones Harlan M. Krumholz Lori Mosca Richard C. Pasternak Thomas Pearson Marc A. Pfeffer Kathryn A. Taubert | 2006 | Circulation2006，，19： | 1 |
| 12 | Clustering of personality traits in youth and the subsequent development of cancer among physicians显示文摘 | John W. Shaffer Pirkko L. Graves Robert T. Swank Thomas A. Pearson | 1987 | Journal of Behavioral Medicine1987，，5： | 1 |
| 13 | Detection of telomerase activity in breast masses by fine-needle aspiration显示文摘 | A. Scott Pearson MD Lauren S. Gollahon PhD Nancy C. O’Neal MD Hossein Saboorian MD Jerry W. Shay PhD Thomas J. Fahey MD | 1998 | Annals of Surgical Oncology1998，，2： | 1 |
| 14 | Association of Lipoprotein-Associated Phospholipase A2 with Coronary Artery Disease in African-Americans and Caucasians显示文摘 | Erdembileg Anuurad Zeynep Ozturk Byambaa Enkhmaa Thomas A. Pearson Lars Berglund | 2010 | The Journal of Clinical Endocrinology & Metabolism2010，，： | 1 |
| 15 | A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial显示文摘 | Thomas A. Pearson Margo A. Denke Patrick E. McBride Wendy P. Battisti William E. Brady Joanne Palmisano | 2005 | Mayo Clinic Proceedings2005，，5： | 1 |
| 16 | Principles for National and Regional Guidelines on Cardiovascular Disease Prevention: A Scientific Statement From the World Heart and Stroke Forum显示文摘 | Sidney C. Smith Rod Jackson Thomas A. Pearson Valentin Fuster Salim Yusuf Ole Faergeman David A. Wood Michael Alderman John Horgan Philip Home Marilyn Hunn Scott M. Grundy | 2004 | Circulation: Journal of the American Heart Association2004，，25： | 1 |
| 17 | 长期大剂量眼内激素应用的安全性 | Holekamp N.M. Thomas M.A. Pearson A. 司冰心 | 2005 | 世界核心医学期刊文摘(眼科学分册)2005，0，8： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员